PBAXU — Phoenix Biotech Acquisition Cashflow Statement
0.000.00%
Last trade - 00:00- $68.56m
- $69.84m
- 21
- 48
- 51
- 34
Annual cashflow statement for Phoenix Biotech Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.316 | -0.668 |
| Non-Cash Items | 0 | -2.84 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.382 | 2.41 |
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Taxes Payable | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -0.697 | -1.09 |
| Other Investing Cash Flow Items | -179 | 181 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | -179 | 181 |
| Financing Cash Flow Items | 7.91 | — |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 180 | -139 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 1.1 | 41 |